SPX4,121.26-18.80 -0.45%
DIA327.92-0.50 -0.15%
IXIC12,479.23-165.23 -1.31%

NovoCure Q2 EPS $(0.23) Misses $(0.15) Estimate, Sales $140.90M Beat $134.99M Estimate

NovoCure (NASDAQ:NVCR) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 64.29 percent decrease over losses of $(0.14) per share from the

Benzinga · 07/28/2022 07:23
NovoCure (NASDAQ:NVCR) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $(0.15) by 53.33 percent. This is a 64.29 percent decrease over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $140.90 million which beat the analyst consensus estimate of $134.99 million by 4.38 percent. This is a 5.53 percent increase over sales of $133.52 million the same period last year.